Carna Biosciences Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Carna Biosciences Inc with three other
companies in this sector in Japan:
Human Metabolome Technologies Inc
sales of 780.38 million Japanese Yen [US$7.02 million]
of which 90%
was Metabolome analysis business),
Raqualia Pharma Incorporated
(705.24 million Japanese Yen [US$6.35 million]
Greenpeptide Co Ltd
(822.56 million Japanese Yen [US$7.40 million]
During the year ended December of 2016, sales at
Carna Biosciences Inc were ¥811.60 million (US$7.30 million).
decrease of 48.3%
versus 2015, when the company's sales were ¥1.57 billion.